Atlas Trials

Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer

Clinical trial NCT03457779 · COMPLETED

Trial details

NCT number
NCT03457779
Sponsor
Baylor Research Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2018-02-08
Primary completion
2020-04-08
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.